AMRYT PHARMA PLC - SPNR ADR (AMYT)

US03217L1061 - ADR

14.7  +0.01 (+0.07%)

After market: 14.7 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
17.095M
14.17%		58.124M
240.01%		182.607M
214.17%		219.479M
EBITDA
YoY % growth
-17.67M
-8.11%		-20.12M
-13.87%		-977K
95.14%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
-18.037M
-8.35%		-32.775M
-81.71%		-45.442M
-38.65%		N/AN/AN/AN/AN/A
Operating Margin
-105.51%-56.39%-24.89%N/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/A0.01

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 21 Q1 / 22 Q2 / 22 Q3 / 22 Q4 / 22
EPS
Q2Q % growth		0.11N/AN/AN/A
Revenue
Q2Q % growth		56.912M
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/AN/AN/A

Recent Earnings VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
Q4 2020
Q2Q % growth		 -0.28 -0.04-0.24-667.52%
Recent Revenue VS Estimates Surprises

Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .

PeriodReportedEstimateDifferenceSurprise
Q3 2021
Q2Q % growth		 56.519M
14.58%		51.634M4.885M9.46%
Q2 2021
Q2Q % growth		 62.762M
35.89%		51.243M11.519M22.48%
Q1 2021
Q2Q % growth		 48.432M
8.66%		45.703M2.729M5.97%
Q4 2020
Q2Q % growth		 42.522M
-13.10%		42.596M-74.17K-0.17%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A